Roche gets USFDA clearance for highly-sensitive test to aid clinicians in diagnosing B-cell lymphoma Ruchika Sharma14 Jan 2025 4:06 PM ISTBasel: Roche has announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its...
Roche unveils new highly-sensitive B-cell lymphoma test Ruchika Sharma21 Jun 2024 1:45 PM ISTBasel: Roche has announced the launch of the clinically approved, highly-sensitive in-situ hybridisation (ISH) test, the VENTANA Kappa and Lambda...
Late noon chemotherapy reduces toxicity and improves survival in diffuse large B cell lymphoma patients Jacinthlyn Sylvia8 Feb 2023 10:30 AM ISTChronotherapy is a drug intervention at specific times of the day to optimize efficacy and minimize adverse effects. Its value in hematologic...
Medical Bulletin 25/January/2023 Isra Zaman25 Jan 2023 2:45 PM ISTHere are the top medical news for the day:Poor sleep during teenage years may increase subsequent MS risk: Study Insufficient and disturbed sleep...
Timing chemotherapy improves treatment results for female lymphoma patients: Study Isra Zaman25 Jan 2023 9:15 AM ISTIn "chronochemotherapy" the aim is timing the delivery of the drug when the body is least vulnerable to the harmful effects of the drug, while the...
Thyroid lymphoma presenting as slow-growing goiter: case study Dr.Niharika Harsha B1 Sept 2020 4:45 AM ISTRecently researchers reported an unusual presentation of Goitre which on surgical pathology presented as a Thyroid Lymphoma with mixed B cell...
